Yusaku Okada

4.5k total citations
195 papers, 3.5k citations indexed

About

Yusaku Okada is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Yusaku Okada has authored 195 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 92 papers in Surgery, 57 papers in Pulmonary and Respiratory Medicine and 38 papers in Molecular Biology. Recurrent topics in Yusaku Okada's work include Bladder and Urothelial Cancer Treatments (39 papers), Urological Disorders and Treatments (25 papers) and Testicular diseases and treatments (22 papers). Yusaku Okada is often cited by papers focused on Bladder and Urothelial Cancer Treatments (39 papers), Urological Disorders and Treatments (25 papers) and Testicular diseases and treatments (22 papers). Yusaku Okada collaborates with scholars based in Japan, United States and New Zealand. Yusaku Okada's co-authors include Osamu Yoshida, Yoichi Arai, Takahiro Kawakami, Keisei Okamoto, Akito Terai, Mutsushi Kawakita, Toshiro Terachi, Osamu Ogawa, Tatsuhiro Yoshiki and Susumu Kageyama and has published in prestigious journals such as The Lancet, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Yusaku Okada

188 papers receiving 3.4k citations

Peers

Countries citing papers authored by Yusaku Okada

Since Specialization

Citations

This map shows the geographic impact of Yusaku Okada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yusaku Okada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yusaku Okada more than expected).

Fields of papers citing papers by Yusaku Okada

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yusaku Okada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yusaku Okada. The network helps show where Yusaku Okada may publish in the future.

Co-authorship network of co-authors of Yusaku Okada

This figure shows the co-authorship network connecting the top 25 collaborators of Yusaku Okada. A scholar is included among the top collaborators of Yusaku Okada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yusaku Okada. Yusaku Okada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Assessment of Sunitinib-Induced Toxicities and Clinical Outcomes Based on Therapeutic Drug Monitoring of Sunitinib for Patients With Renal Cell Carcinoma 2015 ·Clinical Genitourinary Cancer ·Satoshi Noda, (unknown), (unknown), Tetsuya Yoshida, Susumu Kageyama, Keisei Okamoto, Yusaku Okada, Akihiro Kawauchi, Hiroyuki Onishi, Daiki Hira, Shin‐ya Morita, Tomohiro Terada	67
2	Pharmacokinetic/Pharmacodynamic Analysis of a Hemodialyzed Patient Treated with 25 mg of Sunitinib 2012 ·Case Reports in Oncology ·Satoshi Noda, Susumu Kageyama, (unknown), (unknown), Tetsuya Yoshida, Keisei Okamoto, Yusaku Okada, Shin‐ya Morita, Tomohiro Terada	11
3	DNMT3L Is a Novel Marker and Is Essential for the Growth of Human Embryonal Carcinoma 2010 ·Clinical Cancer Research ·Kahori Minami, Tokuhiro Chano, Takahiro Kawakami, (unknown), Ryoji Kushima, Hidetoshi Okabe, Yusaku Okada, Keisei Okamoto	45
4	Cyclin D1b variant promotes cell invasiveness independent of binding to CDK4 in human bladder cancer cells 2009 ·Molecular Carcinogenesis ·Chul Jang Kim, Kayoko Nishi, Takahiro Isono, Yusuke Okuyama, Yukihiro Tambe, Yusaku Okada, Hirokazu Inoue	28
5	Cervical tumoral calcinosis in a patient on maintenance hemodialysis 2008 ·Nihon Toseki Igakkai Zasshi ·Keiji Isshiki, Jun Nakazawa, Toshiro Sugimoto, Masayoshi Sakaguchi, T Koyama, (unknown), Naoko Takeda, (unknown), Mako Yasuda, (unknown), Shinji Kume, (unknown), Shin‐ichi Araki, (unknown), (unknown), Hiroko Nakamura, Kengo Maeda, (unknown), Takashi Uzu, Shinobu Takahashi, Yusaku Okada	0
6	5‐year interval change in voiding function of orthotopic ileal neobladder 2006 ·International Journal of Urology ·Yoichi Arai, Atsushi Takeda, (unknown), Yusaku Okada, Osamu Ogawa, (unknown)	8
7	Intravesical administration of small interfering RNA targeting PLK-1 successfully prevents the growth of bladder cancer 2005 ·Journal of Clinical Investigation ·Masaki Nogawa, Takeshi Yuasa, Shinya Kimura, Motoyoshi Tanaka, Junya Kuroda, Kiyoshi Sato, Asumi Yokota, Hidekazu Segawa, Yoshinobu Toda, Susumu Kageyama, Tatsuhiro Yoshiki, Yusaku Okada, Taira Maekawa	165
8	XIST unmethylated DNA fragments in male-derived plasma as a tumour marker for testicular cancer 2004 ·The Lancet ·Takahiro Kawakami, Keisei Okamoto, Osamu Ogawa, Yusaku Okada	100
9	Characterization of loss-of-inactive X in Klinefelter syndrome and female-derived cancer cells 2004 ·Oncogene ·Takahiro Kawakami, Cheng Zhang, Takanobu Taniguchi, Chul Jang Kim, Yusaku Okada, Hiroyuki Sugihara, Takanori Hattori, Anthony E. Reeve, Osamu Ogawa, Keisei Okamoto	81
10	Diagnostic potential in bladder cancer of a panel of tumor markers (calreticulin, γ‐synuclein, and catechol‐o‐methyltransferase) identified by proteomic analysis 2004 ·Cancer Science ·Hideaki Iwaki, Susumu Kageyama, Takahiro Isono, Yoshihiko Wakabayashi, Yusaku Okada, Koji Yoshimura, Akito Terai, (unknown), Hiroshi Iwamura, Mutsushi Kawakita, Tatsuhiro Yoshiki	87
11	Detection of Alpha‐Fetoprotein mRNA in Seminoma 1999 ·Journal of Andrology ·Takeshi Yuasa, Tatsuhiro Yoshiki, Osamu Ogawa, Tsutomu Tanaka, Takahiro Isono, (unknown), Kayoko Higuchi, Yusaku Okada, Osamu Yoshida	14
12	Expression of platelet‐derived endothelial cell growth factor in bladder carcinoma 1997 ·Cancer ·Youichi Mizutani, Yusaku Okada, Osamu Yoshida	3
13	Expression of platelet-derived endothelial cell growth factor in bladder carcinoma 1997 ·Cancer ·Youichi Mizutani, Yusaku Okada, (unknown)	46
14	Immunocytochemical Detection of p53 in Cultures of Exfoliated Cells from Urine of Patients with Urothelial Cancers 1996 ·Japanese Journal of Cancer Research ·Hiroshi G. Okuno, Yoshiyuki Kakehi, Osamu Ogawa, Hitoshi Yamada, Enver Özdemir, Yusaku Okada, Osamu Yoshida	4
15	[A case report of reconstructive operation in traumatic tricuspid regurgitation]. 1994 ·PubMed ·(unknown), (unknown), Yusaku Okada, Abe H, Takashi Miura, (unknown)	1
16	IMMUNOHISTOCHEMICAL STUDY OF c-erbB-2 PROTO-ONCOGENE PRODUCT IN PROSTATIC CANCER 1993 ·The Japanese Journal of Urology ·(unknown), Tatsuhiro Yoshiki, (unknown), Yusaku Okada, T Tomoyoshi, Kayoko Higuchi	8
17	Stable formation of the nipple valve in Kock pouch for diversion of the urinary tract. 1989 ·PubMed ·Yusaku Okada, (unknown), K Oishi, Hideo Takeuchi, O Yoshida	17
18	Neurofibromatosis Associated with Renovascular Hypertension due to Stenosis and Aneurysm of the Left Renal Segmental Artery: Report of a Case 1989 ·Urologia Internationalis ·(unknown), Yusaku Okada, Hideo Takeuchi, Osamu Yoshida, Hiroshi Suzuki, (unknown)	4
19	Parathyroid cysts with primary hyperparathyroidism: report of a case. 1983 ·PubMed ·(unknown), Yusaku Okada, (unknown), Osamu Yoshida	3
20	OBSERVATIONS ON THE DAMAGES OF THE COASTAL : VEGETATION II 1962 ·Nihon Seitai Gakkaishi ·(unknown), Yusaku Okada, (unknown)	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact